Aetna modified CPB 0648 for autism spectrum disorder (ASD) evaluation and treatment, effective October 3, 2025. Here's what billing teams need to do.
Aetna updated its autism spectrum disorder coverage policy under CPB 0648 to expand and clarify medical necessity criteria across a wide range of diagnostic and therapeutic services. This policy covers 314 CPT codes and 144 HCPCS codes, touching ASD billing across pediatric neurology, behavioral health, speech therapy, genetic testing, and applied behavior analysis. If your practice bills Aetna for any ASD-related services — diagnostic workups, ABA therapy, psychological testing, or augmentative communication — this update affects your reimbursement and your claim denial exposure.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna |
| Policy | Autism Spectrum Disorders — CPB 0648 |
| Policy Code | CPB 0648 |
| Change Type | Modified |
| Effective Date | October 3, 2025 |
| Impact Level | High |
| Specialties Affected | Pediatric neurology, behavioral health, psychiatry, speech-language pathology, audiology, genetics, occupational therapy, physical therapy |
| Key Action | Audit your ASD charge capture and documentation against updated medical necessity criteria before billing Aetna for CPT codes 96112, 96113, 96130–96133, and ABA codes effective October 3, 2025 |
Aetna Autism Spectrum Disorder Coverage Criteria and Medical Necessity Requirements 2025
The Aetna autism spectrum disorder coverage policy starts with a clear threshold: ASD evaluation and diagnosis are medically necessary when a clinician has identified developmental delays or persistent deficits in social communication and social interaction across multiple contexts. The evaluation must be performed by an appropriately certified or licensed health care professional. That's the gate. Everything else flows from there.
Once that threshold is met, this coverage policy opens up a broad set of billable services. Aetna covers ASD-specific developmental evaluations, cognitive and adaptive behavior evaluations, and speech-language pathology assessments. Psychological testing (CPT 96130, 96131) and neuropsychological testing (CPT 96132, 96133) are covered when selection criteria are met. Developmental test administration under CPT 96112 and 96113 also falls inside the covered range.
For hearing evaluation, Aetna covers formal audiological assessment including frequency-specific brainstem auditory evoked response and otoacoustic emissions. The auditory evoked potential codes — 92650, 92651, 92652, and 92653 — are in scope. EEG services under CPT 95812, 95813, 95816, 95819, and 95822 are covered specifically for symptoms that may indicate seizures. Not for EEG biofeedback. That distinction matters.
Genetic testing coverage requires specific clinical findings. Aetna covers high-resolution chromosome analysis (karyotype) and DNA analysis for fragile X syndrome when the child has mental retardation or mental retardation cannot be excluded — and when there's a family history of fragile X or mental retardation of undetermined etiology. Comparative genomic hybridization (CGH) under CPT 81228, 81229, 81277, and 81349, along with code 0209U, is covered when medical necessity criteria in CPB 0787 are met. Chromosome analysis codes 88245, 88248, 88249, 88261, 88262, 88263, and 88264 also appear in the covered set.
Lead testing under CPT 83655 is covered only when the child shows developmental delay and pica, or lives in a high-risk environment. Selective metabolic testing — including basic metabolic panel (CPT 80047, 80048) and comprehensive metabolic panel (CPT 80053) — is covered when specific clinical findings are present. Those triggers include cyclic vomiting, early seizures, lethargy, hearing impairment, hypotonia, visual impairment, unusual odor, dysmorphic features, evidence of mental retardation, or questionable newborn screening.
Sleep-deprived EEG is covered, but only when the child has clinical seizures, high suspicion of subclinical seizures, or symptoms of developmental regression. Quantitative plasma amino acid assays to detect phenylketonuria are covered. Genetic counseling for parents is covered under CPB 0189 criteria.
For therapy services, Aetna covers PT and OT evaluations for sensorimotor deficits. Psychotherapy codes 90832 through 90840 are covered when selection criteria are met. Psychotherapy codes 90845 through 90853 carry an important restriction — covered for co-morbid medical or psychological conditions, not for neurodevelopmental conditions themselves. That language will drive claim denials if your team bills those codes without documenting a qualifying co-morbidity.
Pharmacotherapy coverage for co-morbidity management is subject to the member's specific drug benefits. Check the plan description before assuming coverage.
Aetna Autism Spectrum Disorder Exclusions and Non-Covered Indications
Aetna draws clear lines on several categories within this coverage policy.
EEG biofeedback is not covered under this policy. The covered EEG codes (95812, 95813, 95816, 95819, 95822) explicitly exclude biofeedback applications. If you're billing EEG with a biofeedback indication, expect a claim denial.
Psychotherapy codes 90845–90853 are not covered when billed for the neurodevelopmental condition itself. Coverage only applies when there's a documented co-morbid medical or psychological condition. Billing these codes for ASD as the primary indication — without a qualifying co-morbid diagnosis — is a denial waiting to happen.
Sleep-deprived EEG without one of the three qualifying conditions (clinical seizures, subclinical seizure suspicion, or documented developmental regression) is not covered. Metabolic testing without the specified clinical triggers is also out of scope. Those triggers include cyclic vomiting, early seizures, lethargy, hearing impairment, hypotonia, visual impairment, unusual odor, dysmorphic features, evidence of mental retardation, or questionable newborn screening.
Genetic testing has narrow coverage triggers. High-resolution chromosome analysis without a family history of fragile X or mental retardation of undetermined etiology does not meet medical necessity. Document the specific clinical justification in the record before ordering or billing.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| ASD-specific developmental evaluation | Covered | 96110, 96112, 96113 | Must be performed by certified/licensed professional |
| Cognitive and adaptive behavior evaluations | Covered | 96130, 96131, 96132, 96133, 96136–96139 | When selection criteria met |
| Speech-language pathology evaluation | Covered | 92521, 92522, 92523, 92524 | Comprehensive communication evaluation |
| Augmentative & alternative communication evaluation | Covered | 92605, 92607, +92608 | Both non-speech-generating and speech-generating devices |
| AAC therapeutic services | Covered | 92606, 92609 | Programming and modification included |
| Formal audiological evaluation (AEP, OAE) | Covered | 92650, 92651, 92652, 92653 | Frequency-specific brainstem AEP or OAE |
| EEG for possible seizures | Covered | 95812, 95813, 95816, 95819, 95822 | Symptoms must suggest seizures — not EEG biofeedback |
| Sleep-deprived EEG | Covered — conditional | 95822 | Only for clinical/subclinical seizures or developmental regression |
| EEG biofeedback | Not Covered | 95812–95822 | Explicitly excluded |
| Video-EEG monitoring | Covered — conditional | Per CPB 0322 criteria | Must meet CPB 0322 criteria |
| Lead testing | Covered — conditional | 83655 | Developmental delay + pica or high-risk environment only |
| Selective metabolic testing | Covered — conditional | 80047, 80048, 80053 | Specific clinical triggers required: cyclic vomiting, early seizures, lethargy, hearing impairment, hypotonia, visual impairment, unusual odor, dysmorphic features, evidence of mental retardation, or questionable newborn screening |
| Chromosome analysis / karyotype | Covered — conditional | 88261, 88262, 88263, 88264, 88245, 88248, 88249 | Family history of fragile X or MR of undetermined etiology required |
| Comparative Genomic Hybridization (CGH) / cytogenomic microarray analysis | Covered — conditional | 81228, 81229, 81277, 81349, 0209U | CGH per CPB 0787 criteria — separate from Fragile X DNA analysis |
| Fragile X DNA analysis (karyotype) | Covered — conditional | Specific Fragile X DNA analysis CPT codes not enumerated in available source data — confirm against full CPB 0648 document | Required: mental retardation present or cannot be excluded, plus family history of fragile X or MR of undetermined etiology |
| Genetic counseling (parents) | Covered | Per CPB 0189 | Parents of a child with autism |
| Psychotherapy (primary codes) | Covered | 90832–90840, +90785 | When selection criteria met |
| Psychotherapy (90845–90853) | Covered — restricted | 90845–90853 | Co-morbid medical/psychological conditions only — NOT for neurodevelopmental condition itself |
| PT/OT evaluation | Covered | Per PT/OT codes | For sensorimotor deficits only |
| Behavior modification | Covered | Per ABA codes | For behavioral co-morbidities |
| Quantitative plasma amino acid assay (PKU) | Covered | Applicable chemistry codes | Standard inclusion |
| Pharmacotherapy for co-morbidities | Covered — plan-specific | N/A | Subject to member's drug benefit; verify plan |
| Health behavior assessment & intervention | Covered | 96156, 96158–96168 | When selection criteria met |
| Neurobehavioral status exam | Covered | 96116, +96121 | When selection criteria met |
| Brief emotional/behavioral assessment | Covered | 96127, 96146 | When selection criteria met |
Aetna Autism Spectrum Disorder Billing Guidelines and Action Items 2025
This policy is complex. With 314 CPT codes and conditional coverage rules stacked throughout, your documentation posture determines your denial rate. Here's what to do before the effective date of October 3, 2025.
| # | Action Item |
|---|---|
| 1 | Audit psychotherapy code usage immediately. Review all claims where your team bills 90845–90853 for Aetna ASD patients. Every one of those claims must link to a co-morbid medical or psychological diagnosis — not ASD itself. Fix your charge capture to require a co-morbid ICD-10 when selecting those codes. |
| 2 | Update EEG documentation templates. For CPT 95812, 95813, 95816, 95819, and 95822, confirm your clinical documentation states the indication is possible seizure activity — not behavioral or biofeedback purposes. One wrong indication code on an EEG claim generates a denial under this coverage policy. |
| 3 | Tighten genetic testing documentation. Before billing 81228, 81229, 81277, 81349, or 0209U, confirm the medical record documents the specific clinical trigger: family history of fragile X, mental retardation of undetermined etiology, or dysmorphic features suggesting a genetic syndrome. Reference CPB 0787 for CGH criteria and CPB 0140 for broader genetic testing criteria. For Fragile X DNA analysis specifically, confirm applicable CPT codes against the full CPB 0648 document — the visible source data does not enumerate those codes individually. |
| 4 | Verify lead testing and metabolic panel triggers are documented. CPT 83655 requires developmental delay plus pica or a high-risk environment. CPT 80047, 80048, and 80053 require documented clinical findings from the policy's trigger list — cyclic vomiting, early seizures, lethargy, hearing impairment, hypotonia, visual impairment, unusual odor, dysmorphic features, or questionable newborn screening. If the record doesn't support the trigger, don't bill it. |
| 5 | Review sleep-deprived EEG orders. Confirm every sleep-deprived EEG order documents one of the three covered indications. No clinical seizures, no subclinical seizure suspicion, no documented developmental regression — no coverage. |
| 6 | Check drug benefits separately for pharmacotherapy. Don't assume pharmacy coverage for co-morbidity management is included. Pull the member's specific plan description for drug benefits before prescribing and billing pharmacotherapy services. |
If your practice has a high volume of Aetna ASD claims and you're not sure how this update interacts with your payer contract or compliance posture, talk to your compliance officer before October 3, 2025.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Autism Spectrum Disorder Under CPB 0648
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 0209U | CPT | Cytogenomic constitutional (genome-wide) analysis, interrogation of genomic regions for copy number |
| 80047 | CPT | Basic metabolic panel (Calcium, ionized) |
| 80048 | CPT | Basic metabolic panel (Calcium, total) |
| 80053 | CPT | Comprehensive metabolic panel |
| 81228 | CPT | Cytogenomic constitutional (genome-wide) microarray analysis; interrogation of genomic regions for copy number |
| 81229 | CPT | Interrogation of genomic regions for copy number and SNP variants |
| 81277 | CPT | Cytogenomic neoplasia (genome-wide) microarray analysis, interrogation of genomic regions for copy number |
| 81349 | CPT | Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities |
| 83655 | CPT | Chemistry examination; lead |
| 88245 | CPT | Chromosome analysis for breakage syndromes; baseline Sister Chromatid Exchange (SCE), 20–25 cells |
| 88248 | CPT | Baseline breakage, score 50–100 cells, count 20 cells, 2 karyotypes |
| 88249 | CPT | Score 100 cells, clastogen stress |
| 88261 | CPT | Chromosome analysis; count 5 cells, 1 karyotype, with banding |
| 88262 | CPT | Count 15–20 cells, 2 karyotypes, with banding |
| 88263 | CPT | Count 45 cells for mosaicism, 2 karyotypes, with banding |
| 88264 | CPT | Analyze 20–25 cells |
| +90785 | CPT | Interactive complexity (add-on) |
| 90832 | CPT | Psychotherapy |
| 90833 | CPT | Psychotherapy |
| 90834 | CPT | Psychotherapy |
| 90835 | CPT | Psychotherapy |
| 90836 | CPT | Psychotherapy |
| 90837 | CPT | Psychotherapy |
| 90838 | CPT | Psychotherapy |
| 90839 | CPT | Psychotherapy |
| 90840 | CPT | Psychotherapy |
| 90845 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 90846 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 90847 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 90848 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 90849 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 90850 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 90851 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 90852 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 90853 | CPT | Other psychotherapy — covered for co-morbid medical or psychological conditions only |
| 92521 | CPT | Evaluation of speech fluency |
| 92522 | CPT | Evaluation of speech sound production |
| 92523 | CPT | Evaluation of speech sound production with language comprehension and expression |
| 92524 | CPT | Behavioral and qualitative analysis of voice and resonance |
| 92605 | CPT | Evaluation for prescription of non-speech-generating AAC device |
| 92606 | CPT | Therapeutic service for non-speech-generating device, including programming and modification |
| 92607 | CPT | Evaluation for prescription for speech-generating AAC device |
| +92608 | CPT | Each additional 30 minutes for speech-generating AAC evaluation (add-on) |
| 92609 | CPT | Therapeutic services for speech-generating device, including programming and modification |
| 92650 | CPT | Auditory evoked potentials; screening of auditory potential with broadband stimuli, automated analysis |
| 92651 | CPT | Auditory evoked potentials; for hearing status determination, broadband stimuli |
| 92652 | CPT | Auditory evoked potentials; for threshold estimation at multiple frequencies |
| 92653 | CPT | Auditory evoked potentials; neurodiagnostic, with interpretation and report |
| 95812 | CPT | EEG extended monitoring; 41–60 minutes — covered for symptoms that may indicate seizures only |
| 95813 | CPT | EEG greater than one hour — covered for symptoms that may indicate seizures only |
| 95816 | CPT | EEG including recording awake and drowsy — covered for symptoms that may indicate seizures only |
| 95819 | CPT | EEG including recording awake and asleep — covered for symptoms that may indicate seizures only |
| 95822 | CPT | EEG recording in coma or sleep only — covered for symptoms that may indicate seizures only |
| 96110 | CPT | Developmental screening with interpretation and report |
| 96112 | CPT | Developmental test administration, first hour |
| 96113 | CPT | Developmental test administration, each additional 30 minutes (add-on) |
| 96116 | CPT | Neurobehavioral status exam |
| +96121 | CPT | Neurobehavioral status exam, each additional hour (add-on) |
| 96127 | CPT | Brief emotional/behavioral assessment |
| 96130 | CPT | Psychological testing evaluation services by physician or qualified professional, first hour |
| 96131 | CPT | Psychological testing evaluation services, each additional hour (add-on) |
| 96132 | CPT | Neuropsychological testing evaluation services by physician or qualified professional, first hour |
| 96133 | CPT | Neuropsychological testing evaluation services, each additional hour (add-on) |
| 96136 | CPT | Psychological or neuropsychological test administration and scoring by physician or qualified professional, first 30 minutes |
| 96137 | CPT | Psychological or neuropsychological test administration and scoring by physician or qualified professional, each additional 30 minutes |
| 96138 | CPT | Psychological or neuropsychological test administration and scoring by technician, two or more tests, first 30 minutes |
| 96139 | CPT | Psychological or neuropsychological test administration and scoring by technician, each additional 30 minutes |
| 96146 | CPT | Psychological or neuropsychological test administration with single automated standardized instrument |
| 96156 | CPT | Health behavior assessment or re-assessment |
| 96158 | CPT | Health behavior intervention |
| 96159 | CPT | Health behavior intervention |
| 96160 | CPT | Health behavior intervention |
| 96161 | CPT | Health behavior intervention |
| 96162 | CPT | Health behavior intervention |
| 96163 | CPT | Health behavior intervention |
| 96164 | CPT | Health behavior intervention |
| 96165 | CPT | Health behavior intervention |
| 96166 | CPT | Health behavior intervention |
| 96167 | CPT | Health behavior intervention |
| 96168 | CPT | Health behavior intervention |
234 additional CPT codes and 144 HCPCS codes appear in the full policy. Review the complete code list at the source policy before updating your charge capture.
Note on HCPCS codes: The full policy includes 144 HCPCS codes. The policy data provided here does not include individual HCPCS code details. Pull the full CPB 0648 document from Aetna directly to confirm which HCPCS codes apply to your service lines.
Note on ICD-10-CM codes: The full policy references 21 ICD-10-CM codes. Individual code details were not included in the source data above. Confirm applicable diagnosis codes against the full CPB 0648 document before billing.
Get the Full Picture for CPT 96130
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.